BNP Paribas Financial Markets Increases Stock Position in Harrow, Inc. (NASDAQ:HROW)

BNP Paribas Financial Markets raised its position in shares of Harrow, Inc. (NASDAQ:HROW - Free Report) by 3,015.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 79,974 shares of the company's stock after purchasing an additional 77,407 shares during the quarter. BNP Paribas Financial Markets owned 0.23% of Harrow worth $3,596,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in HROW. Vanguard Group Inc. increased its stake in shares of Harrow by 1.2% in the first quarter. Vanguard Group Inc. now owns 1,829,805 shares of the company's stock worth $24,208,000 after acquiring an additional 21,253 shares during the period. Oppenheimer & Co. Inc. acquired a new position in Harrow in the third quarter valued at approximately $1,267,000. Penserra Capital Management LLC purchased a new stake in Harrow during the third quarter worth $1,986,000. SG Americas Securities LLC purchased a new position in Harrow in the third quarter valued at $534,000. Finally, Semanteon Capital Management LP purchased a new stake in shares of Harrow during the 3rd quarter worth about $686,000. Hedge funds and other institutional investors own 72.76% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on HROW shares. Craig Hallum boosted their price target on shares of Harrow from $45.00 to $65.00 and gave the stock a "buy" rating in a report on Friday, October 4th. B. Riley decreased their target price on Harrow from $73.00 to $69.00 and set a "buy" rating on the stock in a research report on Wednesday. Finally, Lake Street Capital boosted their price target on Harrow from $45.00 to $55.00 and gave the stock a "buy" rating in a research report on Friday, October 4th.

Harrow Trading Down 1.7 %

Harrow stock traded down $0.66 during trading on Thursday, reaching $37.42. 528,366 shares of the company were exchanged, compared to its average volume of 510,230. The stock's 50 day simple moving average is $47.18 and its two-hundred day simple moving average is $35.07. The company has a debt-to-equity ratio of 3.23, a current ratio of 1.55 and a quick ratio of 1.44. The company has a market capitalization of $1.33 billion, a P/E ratio of -39.81 and a beta of 0.69. Harrow, Inc. has a 52-week low of $9.13 and a 52-week high of $59.23.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.